Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study

INTRODUCTION: Necitumumab plus gemcitabine and cisplatin (GCN) is a standard therapy for patients with advanced lung squamous cell carcinoma (LSqCC). However, the efficacy and tolerability of GCN in second-line or later treatment for patients previously treated with immune checkpoint inhibitors (ICI...

Descripción completa

Detalles Bibliográficos
Autores principales: Murata, Yasunori, Tanzawa, Shigeru, Misumi, Toshihiro, Yoshioka, Hiroshige, Miyauchi, Eisaku, Ninomiya, Kiichiro, Takeshita, Masafumi, Ito, Kensaku, Okamoto, Tatsuro, Sugawara, Shunichi, Kawashima, Yosuke, Hashimoto, Kazuki, Mori, Masahide, Miyanaga, Akihiko, Hayashi, Anna, Tanaka, Hisashi, Honda, Ryoichi, Nojiri, Masafumi, Sato, Yuki, Hata, Akito, Masuda, Ken, Kozuki, Toshiyuki, Kawamura, Takahisa, Suzuki, Takuji, Yamaguchi, Teppei, Asada, Kazuhiro, Tetsumoto, Satoshi, Tanaka, Hiroshi, Watanabe, Satoshi, Umeda, Yukihiro, Yamaguchi, Kakuhiro, Kuyama, Shoichi, Tsuruno, Kosuke, Misumi, Yuki, Kuraishi, Hiroshi, Yoshihara, Ken, Nakao, Akira, Kubo, Akihito, Yokoyama, Toshihiko, Watanabe, Kana, Seki, Nobuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689269/
https://www.ncbi.nlm.nih.gov/pubmed/38046378
http://dx.doi.org/10.1016/j.jtocrr.2023.100593

Ejemplares similares

Ejemplares similares